OKYO

OKYO PHARMA LTD

OKYO·G6724L116·US·Common Stock·Healthcare - Biotechnology-13D/G

OKYO (OKYO PHARMA LTD) is held by 12 institutional investors as of Q2 2026. Largest holders: Woodline Partners LP ($5.5M), BALYASNY ASSET MANAGEMENT L.P. ($870,894), UBS Group AG ($82,514). Net institutional sentiment: Bullish.

12
Holders
$6.6M
Total Value
75% (8)
Consensus
6 buying - 2 selling
13F: Insider & Congress: Updated regularly
OKYO

Smart Money Verdict

View all
Loading verdict
Held by 12 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 7, 2026 · Activists May 15, 2026 · Congress none

InsiderPVPatil Rajkumar V.Buy $5KJul 27, 2026
InsiderDJDempsey Robert JohnBuy $23KJul 22, 2026
InsiderCMCERRONE GABRIELE MBuy $33KJul 21, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.7M(+0.0%)$5.5M0.0%-8.82%
27
Decreased
580,596(-0.7%)$870,8940.0%-8.82%
0
Decreased
55,009(-8.0%)$82,5140.0%-9.29%
0
Increased
37,769(+0.3%)$56,6540.0%-14.43%
21
New
33,255$49,8820.0%+3.33%
28
Unchanged
12,812$19,2180.0%-11.38%
0
Unchanged
12,090$18,1350.0%-16.22%
0
New
11,200$16,8000.0%+3.33%
28
New
10,302$15,4530.0%+3.33%
28
New
6,000$9,0000.0%+3.33%
26
Unchanged
152$2280.0%-22.50%
0
Unchanged
10$150.0%-20.10%
0
OKYOOKYOOKYO PHARMA LTD

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used